Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 8;3(1):e170.
doi: 10.1097/HS9.0000000000000170. eCollection 2019 Feb.

Low Levels of Procalcitonin or Presepsin Combined with Significantly Elevated C-reactive Protein May Suggest an Invasive Fungal Infection in Hematological Patients With Febrile Neutropenia

Igor Stoma  1   2 , Igor Karpov  1 , Anatoly Uss  2 , Svetlana Krivenko  2 , Igor Iskrov  2 , Natalia Milanovich  2 , Svetlana Vlasenkova  2 , Irina Lendina  2 , Kristina Belyavskaya  2 , Veranika Charniak  2
Affiliations

Low Levels of Procalcitonin or Presepsin Combined with Significantly Elevated C-reactive Protein May Suggest an Invasive Fungal Infection in Hematological Patients With Febrile Neutropenia

Igor Stoma et al. Hemasphere. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Spectrum of infectious episodes among patients in the study.
Figure 2
Figure 2
ROC-curves for combinations of sepsis biomarkers in diagnosis of IFIs in hematological patients. IFI = invasive fungal infections.
See this image and copyright information in PMC

References

    1. Tacke D, Buchheidt D, Karthaus M, et al. Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Ann Hematol. 2014;93:1449–1456. doi:10.1007/s00277-014-2108-y. - PubMed
    1. Lamoth F, Calandra T. Early diagnosis of invasive mould infections and disease. J Antimicrob Chemother. 2017;72 suppl_1:i19–i28. doi:10.1093/jac/dkx030. - PubMed
    1. Hoenigl M, Zollner-Schwetz I, Sill H, et al. Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies. Mycoses. 2011;54:454–459. doi:10.1111/j.1439-0507.2010.01881.x. - PubMed
    1. Hope WW, Kruhlak MJ, Lyman CA, et al. Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. J Infect Dis. 2007;195:455–466. doi:10.1086/510535. - PubMed
    1. Marr KA, Balajee SA, McLaughlin L, et al. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis. 2004;190:641–649. doi:10.1086/422009. - PubMed